• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

140 万日本患者中首次中风后两年的复发情况 - 滋贺中风和心脏病发作登记研究。

Two-Year Recurrence After First-Ever Stroke in a General Population of 1.4 Million Japanese Patients - The Shiga Stroke and Heart Attack Registry Study.

机构信息

Department of Public Health, Shiga University of Medical Science.

Department of Public Health, Kindai University Faculty of Medicine.

出版信息

Circ J. 2020 May 25;84(6):943-948. doi: 10.1253/circj.CJ-20-0024. Epub 2020 Apr 29.

DOI:10.1253/circj.CJ-20-0024
PMID:32350232
Abstract

BACKGROUND

Despite many effective strategies for the prevention of recurrent stroke, individuals who survive an initial stroke have been shown to be at high risk of recurrent stroke. The aim of this study was to investigate the current status of stroke recurrence after first-ever stroke using a population-based stroke registry in Japan.

METHODS AND RESULTS

As part of the Shiga Stroke and Heart Attack Registry, the Shiga Stroke Registry is an ongoing population-based stroke registry study that covers approximately 1.4 million residents of Shiga Prefecture, Japan. A total of 1,883 first-ever stroke survivors at 28 days was registered in 2011 and followed-up until the end of 2013. Recurrence was defined as any type of stroke after 28 days from the onset of an index event. Two-year cumulative recurrence rates were estimated using cumulative incidence function methods. Over a mean 2.1-year follow-up period, 120 patients experienced recurrent stroke and 389 patients died without recurrence. The 2-year cumulative recurrence rate was higher in patients with index ischemic stroke (6.8%) than in those with index hemorrhagic stroke (3.8%).

CONCLUSIONS

Two-year cumulative recurrence rate after first-ever stroke remained high, particularly among patients with ischemic stroke, in the present population-based registry study in a real-world setting in Japan. Further intensive secondary prevention strategies are required for these high-risk individuals.

摘要

背景

尽管有许多预防复发性中风的有效策略,但首次中风幸存的个体仍存在较高的中风复发风险。本研究旨在使用日本基于人群的中风登记处调查首次中风后的中风复发现状。

方法和结果

作为滋贺中风和心脏病发作登记处的一部分,滋贺中风登记处是一项正在进行的基于人群的中风登记研究,覆盖了日本滋贺县约 140 万居民。2011 年共登记了 1883 例 28 天内的首次中风幸存者,并随访至 2013 年底。复发定义为指数事件发生后 28 天内的任何类型中风。使用累积发生率函数方法估计 2 年累积复发率。在平均 2.1 年的随访期间,120 名患者经历了中风复发,389 名患者无复发死亡。索引缺血性中风患者(6.8%)的 2 年累积复发率高于索引出血性中风患者(3.8%)。

结论

在日本的真实环境下,本次基于人群的登记研究中,首次中风后的 2 年累积复发率仍然较高,特别是在缺血性中风患者中。需要为这些高风险个体制定更强化的二级预防策略。

相似文献

1
Two-Year Recurrence After First-Ever Stroke in a General Population of 1.4 Million Japanese Patients - The Shiga Stroke and Heart Attack Registry Study.140 万日本患者中首次中风后两年的复发情况 - 滋贺中风和心脏病发作登记研究。
Circ J. 2020 May 25;84(6):943-948. doi: 10.1253/circj.CJ-20-0024. Epub 2020 Apr 29.
2
Two-Year Survival After First-Ever Stroke in a General Population of 1.4 Million Japanese - Shiga Stroke Registry.在一个 140 万日本人的普通人群中,首次中风后的两年生存率 - 滋贺中风登记处。
Circ J. 2018 Sep 25;82(10):2549-2556. doi: 10.1253/circj.CJ-18-0346. Epub 2018 Jul 27.
3
Survival After Ischemic and Hemorrhagic Stroke: A 4-Year Follow-Up at a Mexican Hospital.缺血性和出血性中风后的生存率:墨西哥一家医院的4年随访
J Stroke Cerebrovasc Dis. 2019 Aug;28(8):2109-2114. doi: 10.1016/j.jstrokecerebrovasdis.2019.04.002. Epub 2019 May 24.
4
Long-Term Survival after Stroke in 1.4 Million Japanese Population: Shiga Stroke and Heart Attack Registry.日本140万人口中风后的长期生存情况:滋贺中风与心脏病登记研究
J Stroke. 2020 Sep;22(3):336-344. doi: 10.5853/jos.2020.00325. Epub 2020 Sep 29.
5
Recurrent Stroke and Bleeding Events after Acute Cardioembolic Stroke-Analysis Using Japanese Healthcare Database from Acute-Care Institutions.急性心源性栓塞性卒中后的复发性卒中和出血事件——使用来自急性医疗机构的日本医疗数据库进行分析
J Stroke Cerebrovasc Dis. 2018 Apr;27(4):1012-1024. doi: 10.1016/j.jstrokecerebrovasdis.2017.11.002. Epub 2017 Dec 12.
6
Incidence, Management and Short-Term Outcome of Stroke in a General Population of 1.4 Million Japanese - Shiga Stroke Registry.在一个 140 万日本人的普通人群中,中风的发病率、管理和短期预后——滋贺中风登记。
Circ J. 2017 Oct 25;81(11):1636-1646. doi: 10.1253/circj.CJ-17-0177. Epub 2017 Jun 3.
7
A prospective cohort study of stroke characteristics, care, and mortality in a hospital stroke registry in Vietnam.越南某医院卒中登记处卒中特征、护理和死亡率的前瞻性队列研究。
BMC Neurol. 2012 Dec 3;12:150. doi: 10.1186/1471-2377-12-150.
8
Comparing withdrawal and non-withdrawal of life-sustaining treatment among patients who died from stroke.比较因中风死亡患者中维持生命治疗的撤除与未撤除情况。
Vasc Health Risk Manag. 2015 Sep 3;11:507-10. doi: 10.2147/VHRM.S85814. eCollection 2015.
9
Lower levels of high-density lipoprotein cholesterol on admission and a recurrence of ischemic stroke: a 12-month follow-up of the Fukuoka Stroke Registry.入院时高密度脂蛋白胆固醇水平较低与缺血性脑卒中复发:福冈脑卒中登记研究的 12 个月随访。
J Stroke Cerebrovasc Dis. 2012 Oct;21(7):561-8. doi: 10.1016/j.jstrokecerebrovasdis.2010.12.011. Epub 2011 Mar 4.
10
Incidence and Prognostic Impact of Intracranial Hemorrhage after Endovascular Treatment for Acute Large Vessel Occlusion.急性大血管闭塞血管内治疗后颅内出血的发生率和预后影响。
Cerebrovasc Dis. 2020;49(5):540-549. doi: 10.1159/000510970. Epub 2020 Oct 20.

引用本文的文献

1
Usefulness of automated tractography for outcome prediction in patients with recurrent stroke.自动纤维束成像在复发性中风患者预后预测中的应用价值
J Phys Ther Sci. 2024 Oct;36(10):677-683. doi: 10.1589/jpts.36.677. Epub 2024 Oct 1.
2
Drug utilization pattern of romosozumab and other osteoporosis treatments in Japan, 2019-2021.2019 - 2021年日本罗莫佐单抗及其他骨质疏松症治疗药物的使用模式
J Bone Miner Metab. 2024 Nov;42(6):653-667. doi: 10.1007/s00774-024-01530-6. Epub 2024 Jul 10.
3
Economic effects of dietary salt reduction policies for cardiovascular disease prevention in Japan: a simulation study of hypothetical scenarios.
日本预防心血管疾病的膳食减盐政策的经济影响:假设情景的模拟研究
Front Nutr. 2023 Nov 9;10:1227303. doi: 10.3389/fnut.2023.1227303. eCollection 2023.
4
Cost-effectiveness analysis of cardiac implantable electronic devices with reactive atrial-based antitachycardia pacing.基于反应性心房的抗心动过速起搏的心脏植入式电子设备的成本效益分析。
Europace. 2023 Mar 30;25(3):1087-1099. doi: 10.1093/europace/euad003.
5
One-year recurrence of stroke and death in Lebanese survivors of first-ever stroke: Time-to-Event analysis.黎巴嫩首次中风幸存者的中风复发及死亡一年情况:事件发生时间分析
Front Neurol. 2022 Nov 14;13:973200. doi: 10.3389/fneur.2022.973200. eCollection 2022.
6
A Mobile Health-Based Disease Management Program Improves Blood Pressure in People With Multiple Lifestyle-Related Diseases at Risk of Developing Vascular Disease - A Retrospective Observational Study.一项基于移动健康的疾病管理计划可改善有多种生活方式相关疾病且有血管疾病发生风险人群的血压——一项回顾性观察研究。
Circ Rep. 2022 May 31;4(7):322-329. doi: 10.1253/circrep.CR-22-0024. eCollection 2022 Jul 8.
7
Indicators Predicting Inpatient Mortality in Post-Stroke Patients Admitted to a Chronic Care Hospital: A Retrospective Pilot Study.预测入住慢性病医院的中风后患者住院死亡率的指标:一项回顾性试点研究。
Healthcare (Basel). 2022 Jun 2;10(6):1038. doi: 10.3390/healthcare10061038.
8
Importance of Continuous Monitoring of Stroke Recurrence in the General Population.对普通人群中风复发进行持续监测的重要性。
J Atheroscler Thromb. 2022 Dec 1;29(12):1699-1700. doi: 10.5551/jat.ED202. Epub 2022 May 20.
9
Impacts of treatments on recurrence and 28-year survival of ischemic stroke patients.治疗对缺血性脑卒中患者复发和 28 年生存率的影响。
Sci Rep. 2021 Jul 27;11(1):15258. doi: 10.1038/s41598-021-94757-6.